首页 | 本学科首页   官方微博 | 高级检索  
     

化学发光标记免疫测定法检测卵巢上皮癌患者血清CA125水平
引用本文:任晨春,王文靖,刘国川,张海霞. 化学发光标记免疫测定法检测卵巢上皮癌患者血清CA125水平[J]. 河北医药, 2003, 25(7): 487-488
作者姓名:任晨春  王文靖  刘国川  张海霞
作者单位:300052,天津市中心妇产科医院实验室
摘    要:目的 评价化学发光标记免疫测定法(CLIA)在检测卵巢上皮癌者血清CAl25水平中的价值。方法 应用化学发光标记免疫测定法对203例卵巢上皮癌患者进行血清CAl25的检测,其中浆液性癌72例,粘液性癌37例,宫内膜样癌38例,透明细胞癌13例,未分化癌25例,混合性上皮癌18例。对照组选健康女性共638例。结果 203例患者中阳性184例,敏感度为90.6%,特异性为94.5%,准确度为93、6%。结论 化学发光标记免疫测定法是目前检测卵巢上皮癌患者的最好方法,CAl25抗原测定对卵巢癌患者严重程度的估计及疗效观察有重要临床价值.

关 键 词:卵巢上皮癌 诊断 血清CAl25 化学发光标记免疫测定法
修稿时间:2002-10-10

The detection of serum CA125 in patients with ovarian epithelial cancer by chemical luminal immunoassay
REN Chenchun,WANG Wenjing,LIU Guochuan,et al.. The detection of serum CA125 in patients with ovarian epithelial cancer by chemical luminal immunoassay[J]. Hebei Medical Journal, 2003, 25(7): 487-488
Authors:REN Chenchun  WANG Wenjing  LIU Guochuan  et al.
Affiliation:REN Chenchun,WANG Wenjing,LIU Guochuan,et al.Experimental Department,Tianjin Central Hospital for Obstetrics and Gynecology,Tianjin 3000052
Abstract:Objective To evaluate Chemical Luminal Immunoassay (CLIA) in detecting serum CA125 of patients with ovarian epithelial cancer.Methods The serum CA125 in 203 patients with ovarian epithelial cancer was detected by CLIA.The 638 healthy women were chosen as control subjects.Results There were 184 positive patients among 203 patients.The sensitivity and specificity of serum CA125 were 90.6% and 94.5% respevtively,and accuracy was 93.6%.Conclusion CLIA is the best of all the methods of detecting serum CA125,and the detection of CA125 antigen is quite significant for the prognosis and therapeutic effect in patients with ovarian epithelial cancer.
Keywords:CLIA  ovarian epithelial cancer  CA125
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号